TY - JOUR
T1 - Molecular interaction of the first 3 enzymes of the de novo pyrimidine biosynthetic pathway of Trypanosoma cruzi
AU - Nara, Takeshi
AU - Hashimoto, Muneaki
AU - Hirawake, Hiroko
AU - Liao, Chien Wei
AU - Fukai, Yoshihisa
AU - Suzuki, Shigeo
AU - Tsubouchi, Akiko
AU - Morales, Jorge
AU - Takamiya, Shinzaburo
AU - Fujimura, Tsutomu
AU - Taka, Hikari
AU - Mineki, Reiko
AU - Fan, Chia Kwung
AU - Inaoka, Daniel Ken
AU - Inoue, Masayuki
AU - Tanaka, Akiko
AU - Harada, Shigeharu
AU - Kita, Kiyoshi
AU - Aoki, Takashi
N1 - Funding Information:
This work was supported in part by grants-in-aid for the Targeted Proteins Research Program (TPRP), by scientific research No. 19590436 (to T. Nara) and by the Foundation of Strategic Research Projects in Private Universities (S0991013; to T. Nara) from the Ministry of Education, Culture, Sport, Science, and Technology, Japan (MEXT).
PY - 2012/2/3
Y1 - 2012/2/3
N2 - The first 3 reaction steps of the de novo pyrimidine biosynthetic pathway are catalyzed by carbamoyl-phosphate synthetase II (CPSII), aspartate transcarbamoylase (ATC), and dihydroorotase (DHO), respectively. In eukaryotes, these enzymes are structurally classified into 2 types: (1) a CPSII-DHO-ATC fusion enzyme (CAD) found in animals, fungi, and amoebozoa, and (2) stand-alone enzymes found in plants and the protist groups. In the present study, we demonstrate direct intermolecular interactions between CPSII, ATC, and DHO of the parasitic protist Trypanosoma cruzi, which is the causative agent of Chagas disease. The 3 enzymes were expressed in a bacterial expression system and their interactions were examined. Immunoprecipitation using an antibody specific for each enzyme coupled with Western blotting-based detection using antibodies for the counterpart enzymes showed co-precipitation of all 3 enzymes. From an evolutionary viewpoint, the formation of a functional tri-enzyme complex may have preceded-and led to-gene fusion to produce the CAD protein. This is the first report to demonstrate the structural basis of these 3 enzymes as a model of CAD. Moreover, in conjunction with the essentiality of de novo pyrimidine biosynthesis in the parasite, our findings provide a rationale for new strategies for developing drugs for Chagas disease, which target the intermolecular interactions of these 3 enzymes.
AB - The first 3 reaction steps of the de novo pyrimidine biosynthetic pathway are catalyzed by carbamoyl-phosphate synthetase II (CPSII), aspartate transcarbamoylase (ATC), and dihydroorotase (DHO), respectively. In eukaryotes, these enzymes are structurally classified into 2 types: (1) a CPSII-DHO-ATC fusion enzyme (CAD) found in animals, fungi, and amoebozoa, and (2) stand-alone enzymes found in plants and the protist groups. In the present study, we demonstrate direct intermolecular interactions between CPSII, ATC, and DHO of the parasitic protist Trypanosoma cruzi, which is the causative agent of Chagas disease. The 3 enzymes were expressed in a bacterial expression system and their interactions were examined. Immunoprecipitation using an antibody specific for each enzyme coupled with Western blotting-based detection using antibodies for the counterpart enzymes showed co-precipitation of all 3 enzymes. From an evolutionary viewpoint, the formation of a functional tri-enzyme complex may have preceded-and led to-gene fusion to produce the CAD protein. This is the first report to demonstrate the structural basis of these 3 enzymes as a model of CAD. Moreover, in conjunction with the essentiality of de novo pyrimidine biosynthesis in the parasite, our findings provide a rationale for new strategies for developing drugs for Chagas disease, which target the intermolecular interactions of these 3 enzymes.
KW - Aspartate transcarbamoylase
KW - Carbamoyl-phosphate synthetase II
KW - De novo pyrimidine biosynthetic pathway
KW - Dihydroorotase
KW - Trypanosoma cruzi
UR - http://www.scopus.com/inward/record.url?scp=84863419759&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84863419759&partnerID=8YFLogxK
U2 - 10.1016/j.bbrc.2011.12.148
DO - 10.1016/j.bbrc.2011.12.148
M3 - Article
C2 - 22245425
AN - SCOPUS:84863419759
SN - 0006-291X
VL - 418
SP - 140
EP - 143
JO - Biochemical and Biophysical Research Communications
JF - Biochemical and Biophysical Research Communications
IS - 1
ER -